Trials / Completed
CompletedNCT00225511
Study Evaluating Effexor XR for Major Depression.
Phase III Multi-Center, Double-Blind, Comparative Study of Effexor XR for the Treatment of Depression
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 590 (estimated)
- Sponsor
- Wyeth is now a wholly owned subsidiary of Pfizer · Industry
- Sex
- All
- Age
- 20 Years – 64 Years
- Healthy volunteers
- Not accepted
Summary
Study Evaluating Effexor XR for Major Depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Effexor XR | |
| DRUG | Milnacipran |
Timeline
- Start date
- 2004-06-01
- First posted
- 2005-09-23
- Last updated
- 2007-05-24
Locations
73 sites across 1 country: Japan
Source: ClinicalTrials.gov record NCT00225511. Inclusion in this directory is not an endorsement.